作者
F Chen, KH Chan, Y Jiang, RYT Kao, HT Lu, KW Fan, VCC Cheng, WHW Tsui, IFN Hung, TSW Lee, Y Guan, JSM Peiris, KY Yuen
发表日期
2004/9/1
期刊
Journal of clinical virology
卷号
31
期号
1
页码范围
69-75
出版商
Elsevier
简介
Effective antiviral agents are urgently needed to combat the possible return of severe acute respiratory syndrome (SARS). Commercial antiviral agents and pure chemical compounds extracted from traditional Chinese medicinal herbs were screened against 10 clinical isolates of SARS coronavirus by neutralisation tests with confirmation by plaque reduction assays. Interferon-beta-1a, leukocytic interferon-alpha, ribavirin, lopinavir, rimantadine, baicalin and glycyrrhizin showed antiviral activity. The two interferons were only active if the cell lines were pre-incubated with the drugs 16h before viral inoculation. Results were confirmed by plaque reduction assays. Antiviral activity varied with the use of different cell lines. Checkerboard assays for synergy were performed showing combinations of interferon beta-1a or leukocytic interferon-alpha with ribavirin are synergistic. Since the clinical and toxicity profiles of these …
引用总数
2004200520062007200820092010201120122013201420152016201720182019202020212022202320245201421696112111184726223191674326
学术搜索中的文章